<DOC>
	<DOCNO>NCT00537147</DOCNO>
	<brief_summary>West Nile ( WN ) virus infection emerge disease . Infection WN virus may lead paralysis , coma , death . The purpose study determine safety immune response two-dose regimen WN vaccine healthy adult . The vaccine base live attenuate vaccine develop dengue virus .</brief_summary>
	<brief_title>Safety Immune Response West Nile Virus Vaccine ( WN/DEN4delta30 ) Healthy Adults</brief_title>
	<detailed_description>WN widely distribute Africa Europe , usually associate mild illness . In United States , WN consider public health threat severe illness cause WN infection cause paralysis , coma , death , especially elderly . This study evaluate safety immunogenicity live attenuate chimeric virus , WN/DEN4delta30 , derive DEN4 dengue virus wild-type WN serotypes . This study last least 32 week . Participants Cohort 1 randomly assign receive 1X10^4 plaque-forming unit ( PFU ) WN/DEN4delta30 placebo study entry Day 180 . Cohort 2 randomly assign receive high dose WN/DEN4delta30 , 10^5 PFU , placebo study entry Day 180 . Immediately receive injection , participant observe 30 minute immediate adverse reaction . After vaccination , participant ask monitor temperature three time every day 16 day . Study visit occur every day vaccination Day 16 , follow three additional visit select day Day 180 post-vaccination . Blood collection , medical history , vital sign measurement , target physical exam occur visit . Participants also require keep temperature diary Day 16 vaccination . Female participant urine pregnancy test perform within 60 day study entry , Days 28 , 42 , 150 , 180 , 208 , 222 . Pregnancy prevention counsel occur select visit .</detailed_description>
	<mesh_term>West Nile Fever</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Good general health Available duration trial Willing use acceptable form contraception duration study Clinically significant neurologic , heart , lung , liver , rheumatologic , autoimmune , kidney disease Behavioral , cognitive , psychiatric disease , opinion investigator , affect ability volunteer understand cooperate study Neutropenia ( abnormally low neutrophil count ) Alcohol drug abuse within 12 month prior study entry Elevated level alanine aminotransferase ( ALT ) serum creatinine History severe allergic reaction anaphylaxis Severe asthma HIV1 infect Hepatitis C virus infect Hepatitis B surface antigen positive Known immunodeficiency syndrome Use corticosteroid immunosuppressive drug within 30 day study entry . Participants use topical nasal corticosteroid exclude . Live vaccine within 4 week prior study entry Killed vaccine within 2 week prior study entry Surgical removal spleen Blood product within 6 month prior study entry History dengue virus infection flavivirus infection ( e.g. , yellow fever virus , St. Louis encephalitis , West Nile virus ) Previously receive licensed experimental yellow fever dengue vaccine Investigational agent within 30 day study entry Other condition , opinion investigator , would affect participant 's participation study Pregnancy breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>Chimeric West Nile Virus</keyword>
	<keyword>West Nile Virus</keyword>
	<keyword>Dengue Virus</keyword>
</DOC>